Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Retained Earnings: 2016-2025

Historic Retained Earnings for Anaptysbio (ANAB) over the last 9 years, with Sep 2025 value amounting to -$822.2 million.

  • Anaptysbio's Retained Earnings fell 11.47% to -$822.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$822.2 million, marking a year-over-year decrease of 11.47%. This contributed to the annual value of -$759.3 million for FY2024, which is 23.65% down from last year.
  • According to the latest figures from Q3 2025, Anaptysbio's Retained Earnings is -$822.2 million, which was up 1.80% from -$837.3 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Retained Earnings registered a high of -$282.1 million during Q1 2021, and its lowest value of -$837.3 million during Q2 2025.
  • Moreover, its 3-year median value for Retained Earnings was -$704.7 million (2024), whereas its average is -$684.8 million.
  • Its Retained Earnings has fluctuated over the past 5 years, first climbed by 2.82% in 2021, then crashed by 46.63% in 2022.
  • Quarterly analysis of 5 years shows Anaptysbio's Retained Earnings stood at -$321.8 million in 2021, then crashed by 40.01% to -$450.5 million in 2022, then slumped by 36.32% to -$614.1 million in 2023, then fell by 23.65% to -$759.3 million in 2024, then dropped by 11.47% to -$822.2 million in 2025.
  • Its last three reported values are -$822.2 million in Q3 2025, -$837.3 million for Q2 2025, and -$798.7 million during Q1 2025.